Skip links

Asensus

As of February 23, 2021, TransEnterix has been renamed Asensus Surgical, Inc.

Along with the name change, the ticker symbol will change to “ASXC” upon the open of trading on Friday, March 5, 2021. Up until that point, the stock will continue to trade under the company name TransEnterix and ticker symbol TRXC.

If you are an existing investor, your ownership will not be impacted. Beginning on March 5, 2021, your holdings will automatically be renamed as Asensus Surgical, ticker symbol ASXC. Up until that point, the stock will continue to show up as TransEnterix and ticker symbol TRXC.

 

Press Releases

Jan 07, 2019
TransEnterix Provides Corporate Update
Sold five Senhance™ Systems globally in fourth quarter of 2018 Achieved preliminary unaudited revenue of approximately $7.4 million for the fourth quarter of 2018 Received Taiwanese FDA approval for the Senhance System instruments in fourth quarter of 2018 Launched Ultrasonic Instrument System in
Read more
Nov 15, 2018
TransEnterix Named to Deloitte’s Technology Fast 500
RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Nov. 15, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced its naming to Deloitte’s 2018 Technology Fast 500
Read more
Displaying 71 - 80 of 265